|
ISRG
|
Healthcare |
Redburn Atlantic |
Upgrade
|
Neutral
→
Buy
|
—
|
$160.2B
|
$450.94
|
+1.1%
|
-0.3%
|
-2.6%
|
+2.2%
|
+0.4%
|
+3.2%
|
|
RACE
|
Consumer Cyclical |
BarclaysB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$58.8B
|
$421.62
|
+0.6%
|
+2.8%
|
-2.5%
|
-1.4%
|
+0.3%
|
+0.6%
|
|
TEAM
|
Technology |
Goldman SachsB |
Upgrade
|
Neutral
→
Buy
|
—
|
$22.7B
|
$173.24
|
-11.9%
|
-17.1%
|
-0.6%
|
-2.1%
|
-1.7%
|
+1.0%
|
|
AA
|
Basic Materials |
Wolfe ResearchB |
Upgrade
|
Underperform
→
Peer Perform
|
—
|
$16.9B
|
$31.47
|
-1.3%
|
-6.4%
|
-3.5%
|
+3.3%
|
-0.6%
|
+4.9%
|
|
GIL
|
Consumer Cyclical |
StifelA+ |
Upgrade
|
Hold
→
Buy
|
—
|
$8.4B
|
$41.29
|
-0.5%
|
+0.1%
|
-1.7%
|
-1.2%
|
-0.4%
|
+3.5%
|
|
MBLY
|
Consumer Cyclical |
Morgan StanleyB |
Upgrade
|
Underweight
→
Equal Weight
|
—
|
$7.9B
|
$16.28
|
-2.3%
|
-2.0%
|
-4.9%
|
+2.9%
|
-4.0%
|
+5.9%
|
|
OWL
|
Financial Services |
OppenheimerA |
Upgrade
|
Perform
→
Outperform
|
—
|
$6.3B
|
$17.18
|
-1.0%
|
-5.4%
|
-2.8%
|
+3.6%
|
-0.6%
|
+3.7%
|
|
FTDR
|
Consumer Cyclical |
William BlairA |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$4.6B
|
$44.50
|
-0.4%
|
-1.1%
|
-0.7%
|
+2.4%
|
-2.0%
|
+2.0%
|
|
RNST
|
Financial Services |
Keefe, Bruyette & WoodsB |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$3.8B
|
$33.13
|
+1.1%
|
+0.7%
|
-3.4%
|
+1.1%
|
+0.7%
|
-1.1%
|
|
RNG
|
Technology |
RosenblattC |
Upgrade
|
Neutral
→
Buy
|
—
|
$3.7B
|
$33.45
|
+11.7%
|
+5.4%
|
-1.1%
|
-3.1%
|
-2.3%
|
+2.2%
|
|
OMCL
|
Healthcare |
BarclaysB |
Upgrade
|
Underweight
→
Equal Weight
|
—
|
$2.0B
|
$38.85
|
+1.9%
|
+1.0%
|
+2.0%
|
+3.4%
|
-5.6%
|
+2.9%
|